Home
Scholarly Works
Planned and completed NCIC CTG trials with BAY...
Conference

Planned and completed NCIC CTG trials with BAY 12-9566, a novel metalloprotease inhibitor (MMPI)

Authors

Seymour L; Hirte H; Goel R; Moore M; Elias I; Kumor K; Humphrey R

Volume

9

Pagination

pp. 76-76

Publisher

KLUWER ACADEMIC PUBL

Publication Date

January 1, 1998

Conference proceedings

ANNALS OF ONCOLOGY

ISSN

0923-7534

Contact the Experts team